from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2858c/aldC

LFCtreatmentdescriptionclass of inhibitor

-0.546

Amikacinug/mL Amikacintranslation

-0.022

Cap5-10ug/mL Capreomycintranslation

0.702

Rox10-50 ug/mL Roxithromycintranslation

-0.128

SM2-5 ug/mL Streptomycintranslation

-1.220

Tet5-10 ug/mL Tetracyclinetranslation

-1.078

Rif0.2-5ug/mL Rifampicintranscription

-0.885

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.421

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-3.147

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.002

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.394

Clofazimine10-13 ug/mL Clofaziminerespiration

0.078

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.337

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.993

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.125

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.364

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.080

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.222

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.329

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.259

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.253

KCN5-20 ug/mL Potassium cyaniderespiration

0.830

NaN30.2-2 mM Sodium aziderespiration

0.109

Nigericin50 uM Nigericinrespiration

-1.267

TRC10-150 ug/mL Triclosanrespiration

-0.836

TRZ10-25 ug/mL Thioridazinerespiration

0.494

Valinomycin0.5-10 uM Valinomycinrespiration

0.836

ZnSO42 mM ZnSO4respiration

-0.111

menadione6-10 ug/mL Menadionerespiration

-0.203

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.253

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.229

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.158

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.076

NRP_1Non-replicating persistence stage 1dosRassociated

0.312

Amp0.2mg/mL AmpicillincellWall

0.035

Cephalexin20-100 ug/mL CephalexincellWall

0.407

Cerulenin0.32-5 ug/mL CerulenincellWall

0.105

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.045

EMB10-20 ug/mL EthambutolcellWall

0.161

Eta12-40 ug/mL EthionamidecellWall

0.277

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.150

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.718

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.639

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.947

BZA0.12 mg/mL BenzamidearomaticAmides

1.226

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.143

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.483

H2O24 mM hydrogen peroxideDNAdamaging

-0.949

Levo10 ug/mL LevofloxacinDNAdamaging

0.451

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.469

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.044

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.637

UVUV-irradiationDNAdamaging

-0.967

ARP41-4 ug/mL Antitubercular compound ARP4?

0.337

Antimycin12.5-50 ug/mL Antimycin A?

-0.125

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.351

PA_110-50 ug/mL Antitubercular compound PA-1?

0.782

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.238

PA8240.2-2 ug/mL PA-824?

0.331

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.408

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.831

Verapamil50 uM Verapamil?

-0.207

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.379

methoxatin10-20 ug/mL Methoxatin?